Pfizer, Moderna vaccines stop infections in real-world study | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 19, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 19, 2025
Pfizer, Moderna vaccines stop infections in real-world study

Coronavirus chronicle

John Tozzi, Bloomberg
28 April, 2021, 09:15 am
Last modified: 28 April, 2021, 12:56 pm

Related News

  • Special health guidelines issued for HSC exams amid covid-19, dengue surge
  • One more dies of Covid, 25 new cases reported in a day
  • Covid-19: One death, 26 new cases reported in 24hrs
  • 7 new Covid-19 cases reported in 24hrs
  • Covid hospitals in Chattogram face ICU, testing kit crisis amid rising infections

Pfizer, Moderna vaccines stop infections in real-world study

CDC report suggests shots cut transmission, not just illnesses

John Tozzi, Bloomberg
28 April, 2021, 09:15 am
Last modified: 28 April, 2021, 12:56 pm
Pfizer, Moderna vaccines stop infections in real-world study

Covid-19 vaccines from Pfizer Inc. and Moderna Inc. effectively prevented coronavirus infections, not just illness, with substantial protection evident two weeks after the first dose, government researchers said.

Two doses of the vaccines provide as much as 90% protection against infection, according to data from US Centers for Disease Control and Prevention study published Monday. Earlier clinical trials had established that the shots also prevent illness, hospitalizations, and deaths.

The study adds to evidence that new vaccines made with messenger RNA technology actually reduce the spread of the virus in real-world conditions. An earlier study in Israel found a single dose of the Pfizer vaccine reduced infections by as much as 85%.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The study is "tremendously encouraging" CDC Director Rochelle Walensky said in a briefing, and new findings "underscore the importance of getting both of the recommended doses of the vaccine in order to get the greatest level of protection against Covid-19, especially as our concerns about variants escalate."

While the research bodes well for halting the spread of the virus and speeding economic recovery, health officials remain concerned. Cases, hospitalizations, and deaths are rising again in the US, and the CDC's head cautioned that a new surge is building with much of the country still susceptible.

'Impending Doom'

Walensky said she had a feeling of "impending doom" as the US appeared to be on a similar trajectory to Europe, where Covid spikes prompted fresh restrictions this month.

The US has administered 143 million doses of Covid vaccines, according to the Bloomberg Vaccine Tracker, and more than 22% of the population has been inoculated.

The CDC studied a group of about 4,000 front-line workers, including health-care personnel, first responders, teachers and service workers from mid-December to mid-March as vaccines rolled out widely. These groups were among the first to be vaccinated, along with the vulnerable elderly, because of their risk of exposure to the virus.

Participants were tested for Covid weekly and surveyed for reports of symptoms. The researchers compared the frequency of Covid infections before and after vaccinations to estimate how effective the shots were at preventing SARS-CoV-2 spread, regardless of whether people felt sick or not.

Both the vaccines from Pfizer and partner BioNTech SE and Moderna require two doses spaced weeks apart. Two weeks after the first dose, the shots appeared to prevent 80% of infections; that rose to 90% two weeks after the second dose, when people were considered fully immunized.

The study included a mix of participants who were tested after developing symptoms as well as infections that were picked up by weekly tests when people were still feeling well. The results didn't break out in detail the vaccine's ability to prevent asymptomatic or minimally symptomatic infections.

"The study demonstrates that these two mRNA vaccines can reduce the risk of all SARS-CoV-2 infections, not just symptomatic infections," the CDC said in a statement.

Estimates of how well the shots prevent infection should be interpreted cautiously, due to a relatively small number of infections confirmed, the CDC said. The agency also didn't have enough data in this study to distinguish between the two vaccines. The study took place before a third vaccine from Johnson & Johnson became widely available.


Disclaimer: This article first appeared on Bloomberg, and is published by special syndication arrangement
 

Top News

Pfizer coronavirus vaccine / Pfizer Covid-19 Vaccine / Pfizer vaccine / Pfizer-19 Vaccine / Pfizer-BioNTech coronavirus vaccine / Moderna Covid-19 Vaccine / Moderna Vaccine / Moderna Inc / Covid -19 / Covid / Covid 19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Pvt sector's foreign loan rises by $454m on stable exchange rate, reserve in three months
    Pvt sector's foreign loan rises by $454m on stable exchange rate, reserve in three months
  • An anti-missile system operates as missiles are launched from Iran, as seen from Tel Aviv, Israel, 18 June 2025. Photo: Reuters
    Khamenei rejects Trump's demand for surrender, Trump says 'good luck'
  • Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?
    Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

MOST VIEWED

  • Infograph: TBS
    Govt to ease loan rules to help foreign firms expand in Bangladesh
  • Google Pay. Photo: Collected
    Google Pay coming to Bangladesh next week
  • Logo of Beximco Group. Photo: Collected
    Beximco defaults on €33m in Germany, Deshbandhu owes Czech bank €4m
  • Global map showing nuclear weapon inventories by country as of January 2025, including deployed, stored, and retired warheads. Source: SIPRI
    How Israel's secret nuclear arsenal comes under spotlight amid attacks on Iran
  • The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy
    Kallyanpur canal project shows how to combat plastic pollution in Dhaka
  • The India-Bangladesh integrated checkpost in Fulbari. Photo: Passang Yolmo via Telegraph India
    Import of boulders from Bhutan to Bangladesh stopped by Indian transporters in Fulbari

Related News

  • Special health guidelines issued for HSC exams amid covid-19, dengue surge
  • One more dies of Covid, 25 new cases reported in a day
  • Covid-19: One death, 26 new cases reported in 24hrs
  • 7 new Covid-19 cases reported in 24hrs
  • Covid hospitals in Chattogram face ICU, testing kit crisis amid rising infections

Features

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

4h | Panorama
The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

1d | Panorama
The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

2d | Wheels
Renowned authors Imdadul Haque Milon, Mohit Kamal, and poet–children’s writer Rashed Rouf seen at Current Book Centre, alongside the store's proprietor, Shahin. Photo: Collected

From ‘Screen and Culture’ to ‘Current Book House’: Chattogram’s oldest surviving bookstore

3d | Panorama

More Videos from TBS

What's going on in Netanyahu's head behind the regime change story?

What's going on in Netanyahu's head behind the regime change story?

4h | TBS World
The type of bomb the US could use if Trump attacks Iran

The type of bomb the US could use if Trump attacks Iran

4h | TBS World
Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

7h | TBS World
AI will replace jobs at tech giant: Amazon CEO

AI will replace jobs at tech giant: Amazon CEO

7h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net